Ask AI

Curbside Consults in T2D Care: Translating Cardiometabolic Evidence Into Primary Care Decisions

Learn best practices for assessing cardiorenal risk in patients with type 2 diabetes (T2D) and integrating novel incretin-based T2D therapies to improve long-term adherence and outcomes, through an expert-written ClinicalThought, downloadable slides, text modules, and a podcast.

Share

Program Content

Activities

CKM risk reduction in T2D care
Looking Beyond A1C in T2D Care: Translating the Latest Cardiometabolic Evidence Into Primary Care Decisions
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 04, 2026

Activities

Beyond A1C in T2D TM 1
Looking Beyond A1C in T2D Care: Cardiovascular and Kidney Risk Assessment
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2026

Expires: August 09, 2027

Beyond A1C in T2D TM 2
Looking Beyond A1C in T2D Care: Incretin-Based Therapy for Cardiometabolic Risk Reduction
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2026

Expires: August 09, 2027

Beyond A1C in T2D TM 3
Looking Beyond A1C in T2D Care: Evidence Integration and Clinical Positioning
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 07, 2026

Expires: August 06, 2027

Activities

Cardiometabolic health in diabetes care
Enhancing Cardiometabolic Health in Diabetes Care With Incretin-Based Therapies
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: June 29, 2026

Expires: June 28, 2027

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk